We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 07 JULY 2022
FTC And DOJ Workshop On Pharmaceutical Mergers Highlights Potential For Heightened Scrutiny By Enforcers
Winston Taylor
The U.S. Federal Trade Commission (FTC) and Department of Justice, Antitrust Division (DOJ) recently hosted a two-day virtual workshop titled "The Future of Pharmaceuticals: Examining the Analysis...
United StatesAntitrust/Competition Law











